Navigation Links
Efficiently Insert Unique Restriction Sites into Plasmid Vectors


Perform insertion mutagenesis in less than one day

Lisa Breister Jeff Braman
Stratagene

A 28-base insertion was introduced into a plasmid vector using the QuikChange site-directed mutagenesis kit.* The insertion created three unique restriction enzyme digestion sites. Plasmid DNA isolated from 9 out of 12 randomly chosen transformed clones were digested with all 3 restriction enzymes, as judged by gel electrophoresis.

With Stratagenes QuikChange kit,1 performing site-directed mutagenesis is simple, accurate, and efficient. This method permits single and multiple bases to be easily deleted and inserted into any double-stranded plasmid vector, eliminating the need for single-stranded DNA rescue and subcloning into specialized vectors. The kit relies on high-fidelity PfuTurbo DNA polymerase,** which accurately replicates plasmid DNA, thereby minimizing second-site mutations.2 These features make the QuikChange procedure the method of choice for most mutagenesis projects.

Here we describe insertion mutagenesis of a plasmid vector, which resulted in the creation of three unique restriction enzyme recognition sites.

Site-Directed Mutagenesis

To introduce restriction enzyme recognition sites into the plasmid vector, homologous oligonucleotides (49 bases long) were constructed (Figure 1). The oligonucleotides contained ten, 5 terminal bases and eleven, 3 terminal bases homologous to the 6-kb vector. The 28 interior nucleotides destined for insertion into the vector included restriction enzyme recognition sites for Bgl II, Pst I, and Xho I.

Fig.1

Modified pBK388 ve
'"/>

Source:


Page: All 1 2 3

Related biology technology :

1. Unique DNA Polymerase Formulation Excels in a Broad Range of PCR Applications
2. Unique Enhanced DNA Polymerase Delivers High Fidelity and Great PCR Performance
3. A Unique Dimension in Biological Purity
4. Unique Histochemical Substrate Permits Dual Staining In Animal Tissue
5. Unique Surface Treatment of Novel TSK-GEL ODS Columns Provide Separation of Aqueous and Fat Soluble Vitamins
6. Restriction Endonucleases Undergo Rigorous QC Testing to Ensure Optimal Performance
7. Restriction Digests of DNA Isolated with the Perfectprep Gel Cleanup Kit
8. Detection and Identification of Phosphorylation Sites in Proteins Using LC/MS/MS with Neutral Fragment Loss Mapping
9. High-Efficiency Site-Directed Mutagenesis of Large Plasmid Vectors
10. Simple Purification of DNA from Plasmid Minipreps, PCR Amplifications and Agarose Gels
11. Generate High-Quality, Directional Plasmid cDNA Libraries

Post Your Comments:
(Date:11/19/2009)...ewswire/ -- Dr. Mate Hidvegi, inventor of Avemar f...elease issued on November 17 by Biropharma Kft, di...and self-serving statements about its U.S. competi...d from his office in Budapest, Hungary: ,, "Th...t apply to AveULTRA, www.aveultra.com , is misl...
(Date:11/19/2009)...e-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS ), ...ter to its shareholders, discussing the Company,s ...maceuticals Holdings, Inc. (CHBP), an integrated b...public of China. The merger gives NeoStem a contro...o. Ltd., CHBP,s primary operating subsidiary and a...
(Date:11/19/2009)..., Mass., Nov. 19 Arlington Medical...the leading driver of antibiotic selection in noso...ity against gram-positive and gram-negative pathog...e nosocomial pneumonia, surveyed European physicia... provide appropriate coverage against common patho...
(Date:11/19/2009)...e/ - Aegera Therapeutics Inc. announced today the ...2B study of AEG35156, a targeted antisense therape...y indications. ,, The study, entitled "An Open-...ibitor of Apoptosis (XIAP) Antisense AEG35156 Give...rubicin in AML Following Failure of a Single Stand...
Breaking Biology Technology:American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2
... Based on its recent analysis of the cell imaging ...nopoint, Inc. with the 2009 North American Frost &...Year. The company,s cellTRAY(R) Imaging System CT-...ope incubator and integrated fluidics system for i....com/cgi-bin/prnh/20081117/FSLOGO ) , , Cellular ...
...ill Invest in Biotech Start-up Companies Focused o...ENEVA, March 23 Merck Serono, a division of Merck...mation of ,Merck Serono Ventures, a strategic, cor...biotechnology companies. The fund will support bio... provide innovative products in Merck Serono,s cor...
...hough naturally occurring smallpox was eradicated ... obtain smallpox from a laboratory and release it ... supply of smallpox vaccine may be insufficient fo...n the December 2008 issue of The American Journal...tection is obtained from just one vaccination, eve...
Other Biology Technology:Frost & Sullivan Recognizes Nanopoint for its Pioneering Cell Imaging Solution, the cellTRAY(R) Imaging System CT-2000 2Frost & Sullivan Recognizes Nanopoint for its Pioneering Cell Imaging Solution, the cellTRAY(R) Imaging System CT-2000 3Frost & Sullivan Recognizes Nanopoint for its Pioneering Cell Imaging Solution, the cellTRAY(R) Imaging System CT-2000 4Frost & Sullivan Recognizes Nanopoint for its Pioneering Cell Imaging Solution, the cellTRAY(R) Imaging System CT-2000 5Merck Serono Launches Strategic Venture Capital Fund 2Merck Serono Launches Strategic Venture Capital Fund 3New study indicates smallpox vaccination effective for decades 2
(Date:11/19/2009)...many countries of the world. It is widely used for...terials. It also is considered an exemplar plant s...tion, and genome architecture. The authors of the ... the first description of the B73 maize genome to ...etics and plant biology. The ten papers consider m...
(Date:11/19/2009)...19 BIO-key International...eless public safety and finger-based biometric ide...Shareholder Meeting held today was adjourned witho... present. ,, (Logo: http://www.newscom.com/cgi...essive 99.3% of the 35 million votes cast voted in...
(Date:11/19/2009)...University scientists have helped identify and gro...ll development in maize, an effort that expands th...s best suited for biofuels production. , The Pur...or of plant cell biology, published their findings...Physiology on Thursday (Nov. 19). They also were ...
Breaking Biology News(10 mins):PLoS Genetics 2009 maize genome collection 2PLoS Genetics 2009 maize genome collection 3PLoS Genetics 2009 maize genome collection 4BIO-key(R) Provides Update to Special Shareholder Meeting 2BIO-key(R) Provides Update to Special Shareholder Meeting 3Maize cell wall genes identified, giving boost to biofuel research 2Crisis in Aging 3A Disability and Alzheimer 26apos 3Bs 3A Lack of Caregivers Threatens South Florida Seniors 26apos 3B Ability to Stay Home 58441 1Crisis in Aging 3A Disability and Alzheimer 26apos 3Bs 3A Lack of Caregivers Threatens South Florida Seniors 26apos 3B Ability to Stay Home 58441 2Crisis in Aging 3A Disability and Alzheimer 26apos 3Bs 3A Lack of Caregivers Threatens South Florida Seniors 26apos 3B Ability to Stay Home 58441 3Crisis in Aging 3A Disability and Alzheimer 26apos 3Bs 3A Lack of Caregivers Threatens South Florida Seniors 26apos 3B Ability to Stay Home 58441 4Dr Marc Katz Leading Podiatric Surgeon Adds High Powered Color Ultrasound To Cryosurgery Procedures and Treatments 58438 1Dr Marc Katz Leading Podiatric Surgeon Adds High Powered Color Ultrasound To Cryosurgery Procedures and Treatments 58438 2PCPs are front line defense in diagnosing serious illness in patients with acute lower back pain 58435 1PCPs are front line defense in diagnosing serious illness in patients with acute lower back pain 58435 2
...rt-term treatment with a drug compound substantial...syndrome symptoms, say researchers at the Stanford...Children’s Hospital. What’s more, the gains lasted...The researchers are now considering a clinical tri...ct in humans with Down syndrome. , "This treatment...
...ack soya beans could help control weight, lower fa...n of diabetes, reports Lisa Richards in Chemistry ...soya has already been hailed for its cholesterol l...hy frozen food manufacturer Birds Eye has added th...searchers has shown that black soya may be even mo...
...mone to boost athletic performance can lead to dia... the British Journal of Sports Medicine. , The stu...body-builder who required emergency care for chest... which he had also experienced excessive urination...anabolic steroids for 15 years and artificial grow...
Other Biology News:Drug treatment improves learning in mice with Down syndrome symptoms, Stanford/Packard study shows 2Drug treatment improves learning in mice with Down syndrome symptoms, Stanford/Packard study shows 3Drug treatment improves learning in mice with Down syndrome symptoms, Stanford/Packard study shows 4
Mouse Anti-Mouse Qa-1 Monoclonal Antibody, Unconjugated, Clone 6A8.6F10 from Santa Cruz Biotechnology, Inc.
6% PAGE/Urea Solution (19:1 Acrylamide/Bis + 6 M Urea) from Ambion
Rabbit Anti-CDV-1 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
COX-1 Blocking Peptide from Cayman Chemical
Biology Products: